Apellis price target lowered to $18 from $20 at Wedbush

Core Viewpoint - Wedbush has lowered the price target for Apellis (APLS) to $18 from $20 while maintaining a Neutral rating on the shares [1] Financial Performance - The Q4 report from Apellis was largely as anticipated, with the company having preannounced key results in January [1] - Management expects flat Syfovre pricing into FY26, indicating limited growth prospects [1]